Dr. Broxmeyer, who is the Mary Margaret Walther Professor Emeritus of Microbiology and Immunology at the IU School of Medicine, is internationally recognized as a scientific pioneer in the field of umbilical cord blood stem cell transplantation. As one of the first scientists to recognize the value of harvesting stem cells from cord blood, Dr. Broxmeyer was a member of the international team that performed the first cord blood transplant in France in 1988.
Since then, cord blood has been used in transplantation therapy for more than 16,000 patients with dozens of life-threatening diseases such as leukemia, lymphoma, Fanconi anemia and sickle cell anemia.
Dr. Broxmeyer has published more than 650 papers and currently sits on the editorial board of 10 scientific journals. In the past, he has served on the Blood Editorial Board and participated in the subcommittee that shepherded Blood to self-publication in 2000. His major areas of interest include stem/progenitor cell regulation, cytokines and chemokines, and clinical transplantation.
ASH is the world’s largest professional society focused on the causes and treatments of blood disorders. With 16,000 members from 97 countries, ASH’s mission is to further the understanding, diagnosis, treatment and prevention of disorders affecting the blood, bone marrow and blood-related diseases through research, education and clinical care.
Prior to his election as president at the 2009 ASH annual meeting, Dr. Broxmeyer held several offices and was chosen for ASH’s esteemed E. Donnall Thomas Lecture and Prize in 2007.